Rare lephants
Screener

Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 2, 2026 4
8-K Aug 14, 2026 CURRENT REPORT
10-Q Aug 14, 2026 10-Q
8-K May 15, 2026 CURRENT REPORT
10-Q May 15, 2026 10-Q
3 Apr 21, 2026
8-K Apr 17, 2026 CURRENT REPORT
8-K Apr 14, 2026 CURRENT REPORT
8-K Mar 31, 2026 CURRENT REPORT
10-K Mar 31, 2026 10-K
8-K Mar 4, 2026 CURRENT REPORT
8-K Dec 31, 2025 CURRENT REPORT
8-K Dec 22, 2025 CURRENT REPORT
8-K Dec 19, 2025 CURRENT REPORT
8-K Nov 14, 2025 CURRENT REPORT
10-Q Nov 14, 2025 10-Q
8-K Aug 14, 2025 CURRENT REPORT
10-Q Aug 14, 2025 10-Q
8-K Jul 1, 2025 CURRENT REPORT
8-K May 15, 2025 CURRENT REPORT
10-Q May 15, 2025 10-Q
8-K May 6, 2025 CURRENT REPORT
8-K Apr 14, 2025 CURRENT REPORT
10-K Apr 14, 2025 10-K
NT 10-K Apr 1, 2025 NOTIFICATION OF LATE FILING
← Newer Page 1 of 50 · 1238 filings Older →